Work Here?
Overview
MHRA is a government agency in the UK that regulates medicines and medical devices to protect public health. It ensures medicines and devices meet safety and quality standards before they are sold, and it monitors them after they reach the market. The agency operates through three parts: the regulatory centre, which reviews medicines and devices; the National Institute for Biological Standards and Control (NIBSC), which develops and validates biological standards and tests; and the Clinical Practice Research Datalink (CPRD), which collects real-world health data for research to improve care. Unlike private companies that make or sell medical products, MHRA focuses on safety, effectiveness, and quality for the public, and shares findings with manufacturers, clinicians, and the public. Its goal is to enhance and protect the health of millions by making sure medicines and medical devices are safe and effective.”}{
About MHRA
Industries
Government & Public Sector
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
United Kingdom
Founded
1989
Get referred to MHRA
See people who can refer or advise you
Simplify's Take
What believers are saying
- On 22 July 2025, MHRA expanded device market access and cut duplicative approvals.
- Annual Report 2024/25 showed 54 new medicines approved and over 2,000 licenses processed.
- February 2026 and July 2026 board updates show sustained performance and backlog elimination progress.
What critics are saying
- RegulatoryConnect slipped in March 2025, threatening another expensive systems overrun into 2026.
- Lost trading fund status traps surpluses, squeezing hiring, forecasting, and service resilience.
- A prolonged license or device reform failure would erode MHRA credibility and ministerial support.
What makes MHRA unique
- MHRA cleared all statutory licensing backlogs by 31 March 2025.
- MHRA now streamlines medical devices through reliance routes with FDA, TGA, and Health Canada.
- MHRA piloted the world-first AI Airlock, positioning itself in regulated health AI.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Hybrid Work Options
Remote Work Options
Company News
Professor Dennis Whyte has been appointed CEO of the United Kingdom Atomic Energy Authority Group, taking up the role this autumn. Whyte is a co-founder of Rutherford Energy Ventures, a professor at MIT, former director of the MIT Plasma Science and Fusion Center, and co-founder of Commonwealth Fusion Systems. He will oversee UKAEA's fusion research and development, advance commercial pathways, and strengthen international partnerships as the UK works to commercialise fusion energy technologies. Whyte's pioneering work on high-temperature superconducting magnet technology transformed the commercial outlook for magnetic confinement fusion by enabling smaller, more efficient machine designs. "The world is entering a period of unprecedented energy demand," said Whyte. "Achieving commercial fusion will require coordinated efforts across governments, industry, investors, and the scientific community.
Cornish Lithium secures GBP 7.2 million through the UK Government’s DRIVE35 program to support drilling, testing and Direct Lithium Extraction activities.
Cornish Lithium has secured £7.2 million in grant funding from the UK Government's DRIVE35 programme. The grant will part-fund a £14.5 million drilling and testing programme. The funding will enable the company to drill two 2,000-metre production wells and operate a Direct Lithium Extraction demonstration plant at Cross Lanes. It will also support an appraisal well at the nearby Baldhu site to confirm additional lithium resources. The programme aims to advance assessment of technical and economic viability for commercial production at the Cross Lanes Geothermal Lithium Project near Truro. The activities will provide technical information to evaluate the project's potential for commercial lithium production. The project aligns with the UK Government's Industrial Strategy and Critical Minerals Strategy.
Project will create manufacturing line to recover and refine battery-grade lithium from waste streams
Calyo has secured £1.25 million in UK government grant funding through the CAM Pathfinder Demonstrate competition. The Bristol-based deep-tech company is leading DRIVEN BY SOUND+, an 18-month project developing all-weather perception technology for automated vehicles. Working with Benedex and Cranfield University, Calyo will integrate its 3D ultrasound technology with AI computing and vehicle control systems. The Calyo Pulse platform uses ultrasound to generate detailed environmental data, designed to complement cameras, LiDAR and radar in challenging conditions including rain, fog and low light. The project builds on earlier work and aims to deliver an integrated perception subsystem validated at TRL 6-7. The technology has potential applications beyond passenger vehicles, including commercial transport and mobile robotics where robust near-range perception is critical.
MHRA is Hiring for 24 Jobs on Simplify!
Find jobs on Simplify and start your career today
About MHRA
Industries
Government & Public Sector
Company Size
1,001-5,000
Company Stage
N/A
Total Funding
N/A
Headquarters
United Kingdom
Founded
1989
MHRA is Hiring for 24 Jobs on Simplify!
Find jobs on Simplify and start your career today